Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

clinical benefit

- PMLiVE

Coming to an understanding

EphMRA’s Dr Thomas Hein on how market research in pharma has been changing

- PMLiVE

Medical affairs – the time for change is now

The function is uniquely placed to help pharma overcome today’s most pressing healthcare challenges

- PMLiVE

Pfizer signs $900m-plus deal with WAVE for metabolic R&D

Will collaborate on five programmes to explore the cause of genetically defined diseases

- PMLiVE

Celgene creates art gallery to highlight impact of psoriasis

Life's an Itch gallery will be used at meetings and medical conferences

- PMLiVE

Magic Eyes

How patient art can generate broader insights

Publicis

Langland opens New York office

Marks the UK health advertising agency's first over-seas venture

- PMLiVE

Does safety sell medicines?

Is pharmacovigilance unnecessary policing or a strategic asset for pharma companies?

Celgene building

Celgene: Patient voice often underrepresented in pricing debates

Dr Jackie Fouse says in the interests of transparency patients should be more involved

AstraZeneca AZ

AstraZeneca sets up genomics consortium for drug discovery

Will launch dedicated research centre to analyse data from clinical trials

- PMLiVE

Stepping up to payer-driven market access

Giving the industry an opportunity to secure payers’ endorsements of its products by clearly illustrating product value

- PMLiVE

Focusing on value

Merck’s Consumer Health head Uta Kemmerich-Keil on how she wants to add value to her business and society at large

- PMLiVE

FDA approves expanded indication for Gilotrif

US body gives Boehringer Ingelheim’s oral lung cancer treatment the nod

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links